Authors: Grant Murewanhema, Tafadzwa Dzinamarira, Roda Madziva, Helena Herrera, and Godfrey Musuka
In a letter to the editor, ICAP authors call for stronger pharmacovigilance systems in Zimbabwe to assess adverse events related to COVID-19 vaccines.
SARS-Cov-2 Vaccine-Related Adverse Events in Zimbabwe: The Need to Strengthen Pharmacovigilance in Resource-Limited Settings
Available Resources
-
SARS-Cov-2 Vaccine-Related Adverse Events in Zimbabwe: The Need to Strengthen Pharmacovigilance in Resource-Limited Settings
